Showing 31 - 40 of 162,629
A major producer and exporter of formulated, low-cost generic pharmaceuticals, India increased its exports to major … markets during 2011–17, including sub-Saharan Africa (SSA) and the United States. India is also taking steps to produce more … innovative pharmaceuticals through such measures as accessing U.S. technology through mergers, acquisitions, and licensing, and …
Persistent link: https://www.econbiz.de/10012915860
The Colonial Medicine Chest -- The Bazaar and the Indigenous Pharmaceuticals Industry -- For a Pharmacopeia for India …"At present India is a leading producer, distributor, and consumer of generic medicines globally. Disparate Remedies …. The book begins by discussing the expansion of medical consumerism in late nineteenth-century India when British …
Persistent link: https://www.econbiz.de/10014234209
decreasing costs. Pharmaceutical firms in India and China are increasingly forging partnerships with these corporations to gain … intellectual property. Several firms in India and China are performing advanced R&D and are moving into the highest-value segments …
Persistent link: https://www.econbiz.de/10014047447
current patent regime? In India, health being the main concern would necessarily require more sincere efforts on part of the …
Persistent link: https://www.econbiz.de/10014185905
Persistent link: https://www.econbiz.de/10013431125
Persistent link: https://www.econbiz.de/10014425518
Persistent link: https://www.econbiz.de/10013466825
India has one of the most advanced pharmaceutical industries among developing countires. Yet India is critically … imports. In the early 1990s, China was relatively a minor source of bulk drugs imports for India. Imports increased since then … and sharply accelerated after the early 2000s. By the mid-1990s, India was able to successfully develop a pharmaceutical …
Persistent link: https://www.econbiz.de/10013466963
The literature on the Indian pharmaceutical industry has examined the importance of product patents and the attempts policy has made to regulate them. However, it has not done the same for the question of brands. Our study addresses this gap. The Tariff Commission Report of 1968, a turning point...
Persistent link: https://www.econbiz.de/10014636929
Persistent link: https://www.econbiz.de/10009791599